ArticleWorld journal of urology2024
Using three-dimensional virtual imaging of renal masses to improve prediction of robotic-assisted partial nephrectomy Tetrafecta with SPARE score.
Article in World journal of urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Competing-Risk Regression Analysis of Cancer-Specific and Other-Cause Mortality after Partial versus Radical Nephrectomy in T3aN0M0 Renal Cell Carcinoma.Annals of surgical oncology · 2026Article
- Article
- The Integration of Artificial Intelligence into Robotic Cancer Surgery: A Systematic Review.Journal of clinical medicine · 2025Review
- Three-Dimensional Virtual Models in Robot Assisted Partial Nephrectomy: A Needed Tool in the Era of Precision Surgery.Current urology reports · 2025Review
- External validation of current quality care metrics after radical nephroureterectomy.BJU international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo improve the predictability of outcomes in robotic-assisted partial nephrectomy, we utilized three-dimensional virtual imaging for SPARE nephrometry scoring. We compared this method with a conventional two-dimensional scoring system to determine whether 3D virtual images offer enhanced predictive accuracy for Tetrafecta outcomes.
methodsWe retrospectively collected basic information, demographic data, and perioperative indices from patients who underwent robot-assisted partial nephrectomy for renal masses at the Department of Urology, First Affiliated Hospital of Xi'an Jiaotong University. A three-dimensional visualization system (IPS system, Yorktal) was employed to reconstruct the patients' imaging data using AI-based automatic segmentation, resulting in a three-dimensional visualization model (3DVM). This model was then imported into the virtual surgical planning software (Touch Viewer System, Yorktal) for automatic measurement of the SPARE score. Tetrafecta was defined as a warm ischemic time (WIT) of less than 25 min, negative surgical margins, absence of major perioperative complications, and no decline in postoperative renal function. The receiver operating characteristic (ROC) curve was utilized to evaluate the sensitivity and specificity of the SPARE score.
resultsA total of 141 patients were included in this study, with a mean age of 55.6 ± 11.14 years and a mean tumor size of 3.5 ± 1.2 cm. All variables, except for estimated blood loss (EBL) (Coefficient = 0.056, 0.035; P = 0.514, 0.685), showed significant correlation with the SPARE score when comparing CT and 3D virtual models (Tetrafecta: Coefficient = 0.408, 0.56; P < 0.001, < 0.001; WIT: Coefficient = 0.340, 0.237; P < 0.001, 0.007; ΔeGFR: Coefficient = 0.212, 0.257; P = 0.012, 0.002). The area under the curve (AUC) values from the ROC curves indicated that the 3D virtual model group had significantly better performance than the 2D image group for the SPARE score. However, there was no significant difference in the ROC curves for the SPARE complexity category between the two imaging modalities (AUC for SPARE category with 3DVM = 0.658 vs. AUC for SPARE category with CT = 0.643, P = 0.59; AUC for SPARE score with 3DVM = 0.854 vs. AUC for SPARE score with CT = 0.755, P < 0.001).
conclusionsThe SPARE score combined with 3DVM has a more accurate predictive ability for Tetrafecta of RAPN compared to the traditional 2D SPARE score.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.